全文获取类型
收费全文 | 223349篇 |
免费 | 29553篇 |
国内免费 | 7721篇 |
专业分类
耳鼻咽喉 | 1806篇 |
儿科学 | 1849篇 |
妇产科学 | 5594篇 |
基础医学 | 19346篇 |
口腔科学 | 2466篇 |
临床医学 | 18182篇 |
内科学 | 22925篇 |
皮肤病学 | 1769篇 |
神经病学 | 1315篇 |
特种医学 | 6462篇 |
外国民族医学 | 258篇 |
外科学 | 30555篇 |
综合类 | 29406篇 |
现状与发展 | 44篇 |
一般理论 | 3篇 |
预防医学 | 10848篇 |
眼科学 | 297篇 |
药学 | 15382篇 |
134篇 | |
中国医学 | 5080篇 |
肿瘤学 | 86902篇 |
出版年
2024年 | 464篇 |
2023年 | 4425篇 |
2022年 | 6951篇 |
2021年 | 11766篇 |
2020年 | 10904篇 |
2019年 | 9943篇 |
2018年 | 9561篇 |
2017年 | 9936篇 |
2016年 | 10660篇 |
2015年 | 12349篇 |
2014年 | 17889篇 |
2013年 | 17721篇 |
2012年 | 14319篇 |
2011年 | 14787篇 |
2010年 | 10841篇 |
2009年 | 11089篇 |
2008年 | 11339篇 |
2007年 | 10794篇 |
2006年 | 9585篇 |
2005年 | 7937篇 |
2004年 | 6610篇 |
2003年 | 5535篇 |
2002年 | 4838篇 |
2001年 | 4380篇 |
2000年 | 3681篇 |
1999年 | 3153篇 |
1998年 | 2678篇 |
1997年 | 2416篇 |
1996年 | 1969篇 |
1995年 | 1785篇 |
1994年 | 1560篇 |
1993年 | 1245篇 |
1992年 | 1045篇 |
1991年 | 944篇 |
1990年 | 797篇 |
1989年 | 660篇 |
1988年 | 577篇 |
1987年 | 486篇 |
1986年 | 381篇 |
1985年 | 551篇 |
1984年 | 437篇 |
1983年 | 287篇 |
1982年 | 291篇 |
1981年 | 261篇 |
1980年 | 229篇 |
1979年 | 164篇 |
1978年 | 117篇 |
1977年 | 89篇 |
1976年 | 82篇 |
1975年 | 39篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
91.
92.
肺癌是世界上发病率最高的恶性肿瘤之一,外科手术为首选治疗方式。近年来许多新兴微创技术治疗肺癌取得了良好效果。氩氦冷冻消融术因具有损伤小、恢复快、安全性高、并发症少等优点,已取得医患双方认可。冷冻消融适用于不能手术切除的早期肺癌及减少晚期肺癌负荷。肿瘤是一种全身性疾病,因此冷冻消融联合其他治疗方法将是未来肺癌治疗发展方向,从而改善患者临床症状,提高生活质量,延长生存时间,达到最佳治疗效果。该文就冷冻消融治疗及与其他方法综合治疗肺癌研究现状和进展作一综述。 相似文献
93.
94.
目的探讨早期使用十全大补汤联合肠内营养乳剂(TP)治疗胃癌术后(气血两虚证)发生喂养不耐受(FI)的影响因素及对营养指标、中医证候积分的影响。方法回顾性分析术后早期行十全大补汤联合TP治疗的80例胃癌术后(气血两虚)患者的病历资料,根据是否出现FI分为耐受组(34例)和不耐受组(46例)。FI的相关影响因素进行单因素及多因素分析,并观察FI对患者营养指标、中医证候积分的影响。结果单因素分析显示,患者术后第1天下床活动时间、开始肠内营养(EN)的时间、使用营养泵、早期灌肠与FI的发生密切相关(P <0. 05);多因素Logistic回归分析显示,患者第1天下床活动时间≥2 h[OR=0. 022,P=0. 001,95%CI(0. 002,0. 223)]、使用营养泵[OR=0. 021,P=0. 000,95%CI(0. 003,0. 162)]是FI发生的独立危险因素;术后10 d,耐受组患者白蛋白(ALB)、血红蛋白(Hb)升高水平优于不耐受组(P <0. 05),中医证候积分显著低于不耐受组(P <0. 05)。结论胃癌术后(气血两虚证)患者早期给予十全大补汤联合TP治疗开始后,患者第1天下床活动时间不短于2 h、使用营养泵能有效减少FI的发生,并改善了患者的营养状态,减轻了中医临床症状。 相似文献
95.
Maxime Lafond Shin Yoshizawa Shin‐ichiro Umemura 《Journal of ultrasound in medicine》2019,38(3):567-580
Sonodynamic therapy (SDT) consists of the synergetic interaction between ultrasound and a chemical agent. In SDT, the cytotoxicity is triggered by ultrasonic stimuli, notably through cavitation. The unique features of SDT are relevant in the clinical context more than ever: the need for efficacy, accuracy, and safety while being noninvasive and preserving the patient's quality of life. However, despite the promising results of this technique, only a few clinical reports describe the use of SDT. The objective of this article is to provide an extensive overview of the clinical and preclinical research conducted in vivo on SDT, to identify the limitations, and to detail the developed strategies to overcome them. 相似文献
96.
Eric S. Zhou Larissa Nekhlyudov Sharon L. Bober 《Translational andrology and urology》2015,4(2):218-231
There is a large and growing population of long-term cancer survivors. Primary care physicians (PCPs) are playing an increasingly greater role in the care of these patients across the continuum of cancer survivorship. In this role, PCPs are faced with the responsibility of managing a range of medical and psychosocial late effects of cancer treatment. In particular, the sexual side effects of treatment which are common and have significant impact on quality of life for the cancer survivor, often go unaddressed. This is an area of clinical care and research that has received increasing attention, highlighted by the presentation of this special issue on Cancer and Sexual Health. The aims of this review are 3-fold. First, we seek to overview common presentations of sexual dysfunction related to major cancer diagnoses in order to give the PCP a sense of the medical issues that the survivor may present with. Barriers to communication about sexual health issues between patient/PCPs in order are also described in order to emphasize the importance of PCPs initiating this important conversation. Next, we provide strategies and resources to help guide the PCP in the management of sexual dysfunction in cancer survivors. Finally, we discuss case examples of survivorship sexual health issues and highlight the role that a PCP can play in each of these case examples. 相似文献
97.
Puja Vijay Parikh 《International journal of environmental health research》2016,26(4):458-466
Environmental chemical exposure could be an important etiologic factor for geographic differences in breast cancer incidence. In this study, we examined emissions of polycyclic aromatic hydrocarbons (PAHs) and PM2.5 in relation to breast cancer incidence in metro Atlanta and rural Georgia by analyzing data from the Surveillance, Epidemiology, and End Results Program and the Environmental Protection Agency. The results showed that metro Atlanta had a significantly higher age-adjusted annual incidence rate of female breast cancer than rural Georgia (132.6 vs. 113.7 per 100,000) for 1992–2011. Emissions of both PAHs [adjusted β = 0.568 (95 % CI: 0.209, 0.927); p = 0.004] and PM2.5 [adjusted β = 2.964 (95 % CI: 0.468, 5.459); p = 0.023] were significantly associated with breast cancer incidence in metro Atlanta area. This study suggests that ambient air pollution, especially PAHs and PM2.5, could have a significant impact on the increased incidence of female breast cancer in urban areas. 相似文献
98.
Human leukocyte antigens (HLA) alleles may affect the development of cervical cancer through immunologic control of human papillomavirus (HPV). The association between HLA-DQB1 alleles and risk of cervical cancer has been extensively studied, but the results obtained remain inconsistent. To explore a more extensive role of HLA-DQB1 alleles on cervical cancer risk, we carried out a meta-analysis including 4862 cases and 8988 controls from 22 published studies. Odds ratios (ORs) and 95% confidence intervals (CIs) were used to assess the strength of the association. The overall results suggested that HLA-DQB1*02 (OR = 0.91, 95% CI = 0.82–0.99), *03 (OR = 0.85, 95% CI = 0.74–0.97) and *0603 (OR = 0.62, 95% CI = 0.53–0.72) had a significantly association with decreased cervical cancer risk. In contrast, DQB1*05 (OR = 1.18, 95% CI = 1.01–1.38), *0301 (OR = 1.14, 95% CI = 1.06–1.23) and *0402 (OR = 1.31, 95% CI = 1.04–1.64) conferred a significantly higher risk to cervical cancer. Moreover, a significantly association with increased or decreased cervical cancer risk was found among Europeans and Asians after stratification of the HLA-DQB1 alleles by ethnicity. These findings supported that the HLA-DQB1 alleles may contribute to genetic susceptibility of cervical cancer. Further studies with a greater number of cases are expected to confirm our results. 相似文献
99.
100.